PENLARGE

Penumbra, Inc.

HealthcareMedical - Devices
$316.20
$0.01(+0.33%)
52W$221.26
$362.41
Updated Jun 23, 02:00 AM
RSI37
RS Rating54/99
Beta0.18
Volatility33%
F-Score7/9
Mkt Cap$12.4B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Penumbra, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 54), indicating performance broadly in line with the market. Earnings contraction of 18% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
54
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.18
vs S&P 500
LOW VOL
52W Position
67%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$324.17
50 SMA > 100 SMA$331.64
100 SMA > 150 SMA$324.88
150 SMA > 200 SMA$307.70

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$319.82-1.13%BELOW
50 SMA$324.17-2.46%BELOW
100 SMA$331.64-4.65%BELOW
150 SMA$324.88-2.67%BELOW
200 SMA$307.70+2.76%ABOVE

Price Performance

1D+0.3%
1W-0.4%
1M-2.9%
3M-6.2%
6M+0.6%
YTD+2.5%
1Y+23.4%
3Y-2.1%
52-Week Trading Range67% from low
$316.20
52W Low$221.26
52W High$362.41

Technical Indicators

RSI (14)BEARISH
36.6
305070
Setup ScoreCOOL
3/10
Base depth: 6.9%

Risk Profile

Beta
0.18
52W Vol
33%
ATR
$2.32
Max DD (1Y)
-21%

Volume Analysis

Today
201.3K
50D Avg
407.9K
Vol Ratio
0.49x
Liquidity
LIQUID

Earnings Momentum

Q2'25+174%
$1.15
Q3'25+56%
$1.17
Q4'25+40%
$1.20
Q1'26-18%
$0.82
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+22.39%
5 Years:+20.16%
3 Years:+18.33%
TTM:+17.27%

Compounded Profit Growth

10 Years:+49.69%
5 Years:
3 Years:
TTM:+309.43%

Stock Price CAGR

10 Years:+18.02%
5 Years:+3.46%
3 Years:-2.07%
1 Year:+23.42%

Return on Equity

10Y Avg:4.1%
5Y Avg:4.8%
3Y Avg:7.8%
Last Year:12.3%

Key Metrics

Market Cap$12.4B
Gross Margin67.1%
Net Margin12.7%
Piotroski F-Score7/9

Frequently Asked Questions

Is PEN in an uptrend right now?

PEN has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is PEN overbought or oversold?

PEN's RSI (14) is 37. The stock is in neutral territory, neither overbought nor oversold.

Is PEN outperforming the market?

PEN has a Relative Strength (RS) Rating of 54 out of 99. PEN is performing about average compared to the market.

Where is PEN in its 52-week range?

PEN is trading at $316.20, which is 87% of its 52-week high ($362.41) and 67% above its 52-week low ($221.26).

How volatile is PEN?

PEN has a Beta of 0.18 and 52-week volatility of 33%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.